Anti-Factor IX & Factor X Reference Antibody (Emicizumab)
Produktgrößen
100 ug
£495,00
CHBA063-100UG
1 mg
£1135,00
CHBA063-1MG
Über dieses Produkt
- SKU:
- CHBA063
- Zusätzliche Namen:
- Emicizumab
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Anti-BAFF & IL-17A Reference Antibody (Tibulizumab) (CHBA001) is expressed from CHO, with a configuration of IgG-scFv. The heavy chain type is huIgG4SP, and the light chain type is Kappa. It has a predicted MW of 201.44 kDa.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- F9 / Factor IX,Factor X / FXa
- Molekulargewicht:
- 145.62 kDa
- Reinheit:
- >95%
- Aufreinigung:
- Protein A Purified
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -70[o]C Aliquot. Avoid freeze/thaw cycles., -20[o]C Aliquot. Avoid freeze/thaw cycles., 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Recombinant Antibodies
- Datenblatt des Herstellers:CHBA063